Literature DB >> 21156927

Viral-derived Serp-1 as an adjunctive therapy for percutaneous coronary intervention: another not ready for prime time player?

Jane A Leopold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21156927      PMCID： PMC3047481          DOI： 10.1161/CIRCINTERVENTIONS.110.959684

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN： 1941-7640            Impact factor:   6.546


× No keyword cloud information.
  21 in total

Review 1.  The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature.

Authors:  G A Silverman; P I Bird; R W Carrell; F C Church; P B Coughlin; P G Gettins; J A Irving; D A Lomas; C J Luke; R W Moyer; P A Pemberton; E Remold-O'Donnell; G S Salvesen; J Travis; J C Whisstock
Journal:  J Biol Chem       Date:  2001-07-02       Impact factor: 5.157

Review 2.  The serpin saga; development of a new class of virus derived anti-inflammatory protein immunotherapeutics.

Authors:  Alexandra Lucas; Liying Liu; Erbin Dai; Ilze Bot; Kasinath Viswanathan; Ganesh Munuswamy-Ramunujam; Jennifer A Davids; Mee Y Bartee; Jakob Richardson; Alexander Christov; Hao Wang; Colin Macaulay; Mark Poznansky; Robert Zhong; Leslie Miller; Erik Biessen; Mary Richardson; Collin Sullivan; Richard Moyer; Mark Hatton; David A Lomas; Grant McFadden
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

3.  Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries.

Authors:  Gregory J Wilson; Gaku Nakazawa; Robert S Schwartz; Barbara Huibregtse; Bradley Poff; Thomas J Herbst; Donald S Baim; Renu Virmani
Journal:  Circulation       Date:  2009-06-29       Impact factor: 29.690

4.  Inhibition of transplant vasculopathy in a rat aortic allograft model after infusion of anti-inflammatory viral serpin.

Authors:  L W Miller; E Dai; P Nash; L Liu; C Icton; D Klironomos; L Fan; P N Nation; R Zhong; G McFadden; A Lucas
Journal:  Circulation       Date:  2000-04-04       Impact factor: 29.690

5.  High-resolution magnetic resonance imaging enhanced with superparamagnetic nanoparticles measures macrophage burden in atherosclerosis.

Authors:  Kunio Morishige; Daniel F Kacher; Peter Libby; Lee Josephson; Peter Ganz; Ralph Weissleder; Masanori Aikawa
Journal:  Circulation       Date:  2010-10-11       Impact factor: 29.690

6.  Transplant vasculopathy: viral anti-inflammatory serpin regulation of atherogenesis.

Authors:  A Lucas; E Dai; L Liu; H Guan; P Nash; G McFadden; L Miller
Journal:  J Heart Lung Transplant       Date:  2000-11       Impact factor: 10.247

7.  A randomized controlled, phase 2 trial of the viral serpin Serp-1 in patients with acute coronary syndromes undergoing percutaneous coronary intervention.

Authors:  Jean-Claude Tardif; Philippe L L'Allier; Jean Grégoire; Reda Ibrahim; Grant McFadden; William Kostuk; Merril Knudtson; Marino Labinaz; Ron Waksman; Carl J Pepine; Colin Macaulay; Marie-Claude Guertin; Alexandra Lucas
Journal:  Circ Cardiovasc Interv       Date:  2010-11-09       Impact factor: 6.546

8.  Myxoma viral serpin, Serp-1, inhibits human monocyte adhesion through regulation of actin-binding protein filamin B.

Authors:  Kasinath Viswanathan; Jakob Richardson; Babajide Togonu-Bickersteth; Erbin Dai; Liying Liu; Pracha Vatsya; Yun-ming Sun; Jeff Yu; Ganesh Munuswamy-Ramanujam; Henry Baker; Alexandra R Lucas
Journal:  J Leukoc Biol       Date:  2008-12-03       Impact factor: 4.962

9.  Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis.

Authors:  Stéphane Cook; Elena Ladich; Gaku Nakazawa; Parham Eshtehardi; Michel Neidhart; Rolf Vogel; Mario Togni; Peter Wenaweser; Michael Billinger; Christian Seiler; Steffen Gay; Bernhard Meier; Werner J Pichler; Peter Jüni; Renu Virmani; Stephan Windecker
Journal:  Circulation       Date:  2009-07-20       Impact factor: 29.690

10.  Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial.

Authors:  Kristofer Dosh; Peter B Berger; Steven Marso; Fredrick van Lente; Danielle M Brennan; Richard Charnigo; Eric J Topol; Steven Steinhubl
Journal:  Circ Cardiovasc Interv       Date:  2009-11-17       Impact factor: 6.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.